Ajax-Loading

Eli Lilly and Company - Cash Flow Per Share

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD.

The item "Cash-Flow-Per-Share" stands at 19.34 United States Dollars as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Cash Flow Per Share" stands at 19.34 USD. This represents an increase of 53.41 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 177.08 percent compared to the value the year prior.
The 1 year change in percent is 177.08.
The 3 year change in percent is 113.09.

The Serie's long term average value is 8.75 United States Dollars. It's latest available value, on 09/30/2025, is 120.92 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +369.46%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Cash Flow Per Share for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Cash Flow Per Share486,508,953,600.00
LogoAbbVie Inc - Cash Flow Per Share399,570,305,024.00
LogoRoche Holding AG - Cash Flow Per Share317,433,206,677.55
LogoAstraZeneca PLC - Cash Flow Per Share280,205,508,085.11
LogoNovartis AG - Cash Flow Per Share255,096,620,580.91